What is the current Nicorandil Preparations market size?

The current Nicorandil Preparations market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Nicorandil Preparations market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Nicorandil Preparations market?

Key drivers include rising cardiovascular disease prevalence and growing geriatric population, fueling future outlook.

What challenges does the Nicorandil Preparations market face?

Challenges include intense competition, stringent regulatory requirements, and patent expirations affecting market share.

Which regions are leading the Nicorandil Preparations market?

Regional leaders include North America, Europe, and Asia-Pacific, with the latter expected to dominate the market.

Who are the top companies in the Nicorandil Preparations market?

Top companies include Chugai Pharmaceutical, Mitsubishi Tanabe Pharma, and Sanofi, with a strong focus on research and development.

What future opportunities exist in the Nicorandil Preparations market?

Future opportunities include emerging markets, innovative formulations, and combination therapies, driving the market forward.

How is technology impacting the Nicorandil Preparations market?

Technology is improving manufacturing processes, enhancing product quality, and enabling personalized medicine, shaping the market landscape.

What is the current regulatory landscape for Nicorandil Preparations?

The regulatory landscape is characterized by strict guidelines, patent regulations, and quality control measures, ensuring safe and effective products.

Nicorandil Preparations Market 2026: Primary Research + Expert Analysis

Nicorandil Preparations by Application (Hospital, Clinic, Other), by Types (Tablet, Injection), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 5.8%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Nicorandil Preparations Market Overview

The Nicorandil Preparations market refers to the global industry involved in the development, production, and distribution of Nicorandil, a medication used to treat angina. As a key segment of the pharmaceutical industry, the Nicorandil Preparations market size is expected to experience significant growth, driven by an increasing demand for effective treatments for cardiovascular diseases. The market's growth outlook and market forecast indicate a promising industry expansion, with the global Nicorandil Preparations market size estimated to be around USD 823 million in 2025. The market is expected to grow at a CAGR of 4.5% from 2026 to 2033, driven by macro drivers such as an aging population, increasing healthcare expenditure, and advancements in medical technology.

Loading chart…

The Nicorandil Preparations market is shaped by key forces such as technology shifts towards more efficient manufacturing processes, regulations governing the production and distribution of pharmaceuticals, and consumer behavior driven by increasing awareness of cardiovascular health. The largest region in the Nicorandil Preparations market is currently Asia-Pacific, while the fastest-growing region is expected to be Latin America. As the market continues to evolve, industry players must navigate these forces to capitalize on emerging opportunities and maintain a competitive edge in the global Nicorandil Preparations industry.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	1.88 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Actiza Pharmaceutical; Taj Pharmaceuticals; TSUBAME Pharma; Livealthbiopharma; Torrent Pharmaceuticals Ltd; Chugai Pharmaceutical; Beijing Sihuan Kebao Pharmaceutical Co.,Ltd.; Tasly Pharmaceutical Group Co.,Ltd.; YANGTZE River Pharmaceutical Group; Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.; Chengdu Easton Biopharmaceuticals Co.,Ltd.; Henan Topfond Pharmaceutical Co.,Ltd.; Xi`an Han Feng Pharmaceutical Co.,Ltd.; Tonghua Renmin Pharmaceutical Co.,Ltd.; Liaoyuan City Baikang Pharmaceutical Co.,Ltd.; Shanxi Xinyu Pharmaceutical Co.,Ltd.; Shijiazhuang No.4 Pharmaceutical Co.,Ltd.; Pingguang Pharmaceutical Limited; Cardiatic Care
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Nicorandil Preparations market is experiencing significant transformations, driven by various factors. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Increasing prevalence of cardiovascular diseases, particularly angina pectoris, is driving the demand for Nicorandil Preparations and contributing to the growth forecast of the market.

Advancements in drug delivery technologies and the development of more effective formulations are further boosting the Nicorandil Preparations market size.

Restraints2 items

Stringent regulatory requirements and the need for extensive clinical trials are limiting the entry of new players into the Nicorandil Preparations market and affecting its growth.

Side effects associated with Nicorandil, such as headache and hypotension, are also acting as restraints to the market's expansion, impacting the overall growth forecast.

Opportunities2 items

Emerging economies with a large patient population and growing healthcare infrastructure present significant opportunities for the Nicorandil Preparations market to expand.

The increasing focus on personalized medicine and targeted therapies is expected to create new avenues for Nicorandil Preparations, contributing to the market's future growth.

Challenges2 items

Competition from alternative treatments and drugs, such as nitrates and beta-blockers, poses a significant challenge to the Nicorandil Preparations market size and its growth prospects.

Fluctuations in the global economy and pricing pressures can impact the profitability of Nicorandil Preparations manufacturers, affecting the market's overall growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Nicorandil Preparations market refers to the various uses of Nicorandil in the medical field. This segment is crucial in understanding the Nicorandil Preparations market size, as it highlights the different areas where Nicorandil is applied, such as in the treatment of angina pectoris and other cardiovascular diseases. The Nicorandil Preparations segmentation by application provides valuable insights into the market, enabling stakeholders to identify opportunities and trends in the industry.

The Types segment of the Nicorandil Preparations market is further divided into subtypes, including [object Object] and [object Object]. This segmentation is essential in understanding the market taxonomy of Nicorandil Preparations, as it allows for a detailed analysis of the different types of Nicorandil preparations available in the market. By examining the various subtypes, stakeholders can gain a deeper understanding of the Nicorandil Preparations market and make informed decisions about their investments and strategies.

Nicorandil Preparations Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

Tablet

Injection

Regional Insights

Loading chart…

The Nicorandil Preparations market growth is anticipated to be driven by various regional factors. The largest region, Asia Pacific, accounts for approximately 40% of the market share, driven by key drivers such as increasing adoption of Nicorandil Preparations, favorable policies, and significant investments in the healthcare sector. The fastest-growing region, Latin America, is expected to witness significant growth due to improving demographics, developing infrastructure, and growing ecosystem maturity.

In North America, the Nicorandil Preparations market is driven by factors such as high adoption rates, stringent policies, and significant investments in research and development. Europe is driven by factors such as increasing demographics, favorable policies, and growing ecosystem maturity. The Middle East & Africa region is driven by factors such as improving infrastructure, growing demographics, and increasing adoption of Nicorandil Preparations. The regional forecast indicates that the Asia Pacific region will continue to dominate the market, while Latin America will witness the highest growth rate.

Key Drivers by Region5 items

North America: high adoption rates, stringent policies, significant investments

Europe: increasing demographics, favorable policies, growing ecosystem maturity

Asia Pacific: increasing adoption, favorable policies, significant investments

Latin America: improving demographics, developing infrastructure, growing ecosystem maturity

Middle East & Africa: improving infrastructure, growing demographics, increasing adoption

Competitive Landscape

The Nicorandil Preparations market is moderately consolidated, with a mix of global players and local/regional companies. The Nicorandil Preparations competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and regulatory approvals, while local companies are concentrating on pricing and distribution.

Companies in the Nicorandil Preparations market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies need to focus on technology, service model, channel strength, customization, and cost advantages.

Actiza Pharmaceutical: regional expansion

Taj Pharmaceuticals: vertical integration

TSUBAME Pharma: premium pricing

Livealthbiopharma: OEM tie-ups

Torrent Pharmaceuticals Ltd: innovation pipeline

Chugai Pharmaceutical: local manufacturing

Key Nicorandil Preparations Companies19 items

Actiza Pharmaceutical

Taj Pharmaceuticals

TSUBAME Pharma

Livealthbiopharma

Torrent Pharmaceuticals Ltd

Chugai Pharmaceutical

Beijing Sihuan Kebao Pharmaceutical Co.,Ltd.

Tasly Pharmaceutical Group Co.,Ltd.

YANGTZE River Pharmaceutical Group

Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.

Chengdu Easton Biopharmaceuticals Co.,Ltd.

Henan Topfond Pharmaceutical Co.,Ltd.

Xi`an Han Feng Pharmaceutical Co.,Ltd.

Tonghua Renmin Pharmaceutical Co.,Ltd.

Liaoyuan City Baikang Pharmaceutical Co.,Ltd.

Shanxi Xinyu Pharmaceutical Co.,Ltd.

Shijiazhuang No.4 Pharmaceutical Co.,Ltd.

Pingguang Pharmaceutical Limited

Cardiatic Care

Market Ecosystem

The Nicorandil Preparations ecosystem encompasses a complex network of participants, spanning from upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three stages: upstream, midstream, and downstream, with value created and captured through the interactions and relationships between these stages. The Nicorandil Preparations ecosystem is characterized by the flow of goods, services, and information from technology providers and suppliers to integrators, channels, and ultimately, end users.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing Nicorandil Preparations

Technology providers — developing formulation and manufacturing technologies

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — establishing and enforcing quality standards

Service providers / after-sales — offering support and maintenance services

End users / buyers — consuming Nicorandil Preparations for therapeutic purposes

In the Nicorandil Preparations ecosystem, control points are primarily influenced by regulators and standards bodies, which dictate the quality and safety standards of the preparations. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and approvals from regulatory bodies. Switching costs and partnerships between participants can also impact the ecosystem, particularly in terms of interoperability requirements. Furthermore, the ecosystem may differ by region due to varying regulatory frameworks and market conditions, highlighting the need for a comprehensive value chain analysis to navigate these complexities.

Recent Industry Insights

The Nicorandil Preparations industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships have been forged to enhance research and development capabilities, while mergers and acquisitions have led to consolidation and expansion of market share. Additionally, several product launches have taken place, introducing new formulations and delivery systems. Regulatory changes have also impacted the industry, with updates to guidelines and standards for manufacturing and quality control. Furthermore, there has been a notable shift in consumer trends, with an increasing emphasis on personalized medicine and targeted therapies. Funding rounds and expansions have also been announced, providing a boost to the industry's growth prospects.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Nicorandil Preparations market. The market attractiveness is moderate, driven by growing demand for effective treatments of angina. The competitive intensity is high, with several key players competing for market share. The long-term outlook for the Nicorandil Preparations market outlook is promising, with opportunities for innovation and expansion into new markets.

The innovation landscape is evolving, with a focus on improved formulations and delivery systems. However, the demand–supply balance is a key risk factor, as fluctuations in supply can impact market stability. Other risk factors include regulatory changes and intense competition. Overall, the Nicorandil Preparations market is expected to experience steady growth, driven by increasing demand and innovation.

12 items

1. Executive Summary

2. Nicorandil Preparations Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nicorandil Preparations Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Nicorandil Preparations Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Nicorandil Preparations Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Nicorandil Preparations Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Nicorandil Preparations Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Nicorandil Preparations Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Nicorandil Preparations Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Nicorandil Preparations Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Nicorandil Preparations Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Nicorandil Preparations Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nicorandil Preparations Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nicorandil Preparations Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Nicorandil Preparations Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Nicorandil Preparations Market Competition by Key Manufacturers

9.1. Global Nicorandil Preparations Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Nicorandil Preparations: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Actiza Pharmaceutical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Taj Pharmaceuticals

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. TSUBAME Pharma

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Livealthbiopharma

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Torrent Pharmaceuticals Ltd

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Chugai Pharmaceutical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Beijing Sihuan Kebao Pharmaceutical Co.,Ltd.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Tasly Pharmaceutical Group Co.,Ltd.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. YANGTZE River Pharmaceutical Group

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Chengdu Easton Biopharmaceuticals Co.,Ltd.

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Henan Topfond Pharmaceutical Co.,Ltd.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Xi`an Han Feng Pharmaceutical Co.,Ltd.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Tonghua Renmin Pharmaceutical Co.,Ltd.

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Liaoyuan City Baikang Pharmaceutical Co.,Ltd.

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shanxi Xinyu Pharmaceutical Co.,Ltd.

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Shijiazhuang No.4 Pharmaceutical Co.,Ltd.

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Pingguang Pharmaceutical Limited

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Cardiatic Care

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nicorandil Preparations Market

Figure 4: Global Nicorandil Preparations Market: Drivers

Figure 5: Global Nicorandil Preparations Market: Challenges

Figure 6: Global Nicorandil Preparations Market: Trends

Figure 7: Global Nicorandil Preparations Market: Opportunity

Figure 8: Global Nicorandil Preparations Market: Restraint

Figure 9: Global Nicorandil Preparations Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Nicorandil Preparations Market Value (USD Million) By Region

Figure 19: Global Nicorandil Preparations Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Nicorandil Preparations Market Value (USD Million) By Region

Figure 27: Global Nicorandil Preparations Market Share (%) By: Regions (2032)

Figure 28: Global Nicorandil Preparations Market Volume (K) By Region

Figure 29: Global Nicorandil Preparations Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Nicorandil Preparations Market Value (USD Million) By Region

Figure 37: Global Nicorandil Preparations Market Share (%) By: Regions (2032)

Figure 38: Global Nicorandil Preparations Market Volume (K) By Region

Figure 39: Global Nicorandil Preparations Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

133 items

Table 1: Market Segmentation Analysis

Table 2: Global Nicorandil Preparations Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nicorandil Preparations Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nicorandil Preparations Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Nicorandil Preparations Market Value (USD Million) By Region

Table 14: Global Nicorandil Preparations Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Nicorandil Preparations Market Volume (K) By Region

Table 31: Global Nicorandil Preparations Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Nicorandil Preparations Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Nicorandil Preparations Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Nicorandil Preparations Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Actiza Pharmaceutical Basic Information And Sales Area

Table 52: Actiza Pharmaceutical. Products Portfolio

Table 53: Taj Pharmaceuticals Basic Information And Sales Area

Table 54: Taj Pharmaceuticals. Products Portfolio

Table 55: TSUBAME Pharma Basic Information And Sales Area

Table 56: TSUBAME Pharma. Products Portfolio

Table 57: Livealthbiopharma Basic Information And Sales Area

Table 58: Livealthbiopharma. Products Portfolio

Table 59: Torrent Pharmaceuticals Ltd Basic Information And Sales Area

Table 60: Torrent Pharmaceuticals Ltd. Products Portfolio

Table 61: Chugai Pharmaceutical Basic Information And Sales Area

Table 62: Chugai Pharmaceutical. Products Portfolio

Table 63: Beijing Sihuan Kebao Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 64: Beijing Sihuan Kebao Pharmaceutical Co.,Ltd.. Products Portfolio

Table 65: Tasly Pharmaceutical Group Co.,Ltd. Basic Information And Sales Area

Table 66: Tasly Pharmaceutical Group Co.,Ltd.. Products Portfolio

Table 67: YANGTZE River Pharmaceutical Group Basic Information And Sales Area

Table 68: YANGTZE River Pharmaceutical Group. Products Portfolio

Table 69: Shanghai Fosun Pharmaceutical(Group)Co.,Ltd. Basic Information And Sales Area

Table 70: Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.. Products Portfolio

Table 71: Chengdu Easton Biopharmaceuticals Co.,Ltd. Basic Information And Sales Area

Table 72: Chengdu Easton Biopharmaceuticals Co.,Ltd.. Products Portfolio

Table 73: Henan Topfond Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 74: Henan Topfond Pharmaceutical Co.,Ltd.. Products Portfolio

Table 75: Xi`an Han Feng Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 76: Xi`an Han Feng Pharmaceutical Co.,Ltd.. Products Portfolio

Table 77: Tonghua Renmin Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 78: Tonghua Renmin Pharmaceutical Co.,Ltd.. Products Portfolio

Table 79: Liaoyuan City Baikang Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 80: Liaoyuan City Baikang Pharmaceutical Co.,Ltd.. Products Portfolio

Table 81: Shanxi Xinyu Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 82: Shanxi Xinyu Pharmaceutical Co.,Ltd.. Products Portfolio

Table 83: Shijiazhuang No.4 Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 84: Shijiazhuang No.4 Pharmaceutical Co.,Ltd.. Products Portfolio

Table 85: Pingguang Pharmaceutical Limited Basic Information And Sales Area

Table 86: Pingguang Pharmaceutical Limited. Products Portfolio

Table 87: Cardiatic Care Basic Information And Sales Area

Table 88: Cardiatic Care. Products Portfolio

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Value (USD Million) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Volume (K) (2025-2032) By Types

Table 96: Global Market Share (%) By Types (2032)

Table 97: Global Nicorandil Preparations Market Value (USD Million) By Region

Table 98: Global Nicorandil Preparations Market Share (%) By Region (2025-2032)

Table 99: North America Market Value (USD Million) (2025-2032) By Country

Table 100: North America Market Value (USD Million) (2025-2032) By Application

Table 101: North America Market Value (USD Million) (2025-2032) By Types

Table 102: Europe Market Value (USD Million) (2025-2032) By Country

Table 103: Europe Market Value (USD Million) (2025-2032) By Application

Table 104: Europe Market Value (USD Million) (2025-2032) By Types

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 106: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 108: South America Market Value (USD Million) (2025-2032) By Country

Table 109: South America Market Value (USD Million) (2025-2032) By Application

Table 110: South America Market Value (USD Million) (2025-2032) By Types

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 112: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 114: Global Nicorandil Preparations Market Volume (K) By Region

Table 115: Global Nicorandil Preparations Market Share (%) By Region (2025-2032)

Table 116: North America Market Volume (K) (2025-2032) By Country

Table 117: North America Market Volume (K) (2025-2032) By Application

Table 118: North America Market Volume (K) (2025-2032) By Types

Table 119: Europe Market Volume (K) (2025-2032) By Country

Table 120: Europe Market Volume (K) (2025-2032) By Application

Table 121: Europe Market Volume (K) (2025-2032) By Types

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 123: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 125: South America Market Volume (K) (2025-2032) By Country

Table 126: South America Market Volume (K) (2025-2032) By Application

Table 127: South America Market Volume (K) (2025-2032) By Types

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 129: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 131: Research Programs/Design For This Report

Table 132: Key Data Information From Secondary Sources

Table 133: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Nicorandil Preparations Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	1.88 million
Growth rate	CAGR of 5.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Actiza Pharmaceutical; Taj Pharmaceuticals; TSUBAME Pharma; Livealthbiopharma; Torrent Pharmaceuticals Ltd; Chugai Pharmaceutical; Beijing Sihuan Kebao Pharmaceutical Co.,Ltd.; Tasly Pharmaceutical Group Co.,Ltd.; YANGTZE River Pharmaceutical Group; Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.; Chengdu Easton Biopharmaceuticals Co.,Ltd.; Henan Topfond Pharmaceutical Co.,Ltd.; Xi`an Han Feng Pharmaceutical Co.,Ltd.; Tonghua Renmin Pharmaceutical Co.,Ltd.; Liaoyuan City Baikang Pharmaceutical Co.,Ltd.; Shanxi Xinyu Pharmaceutical Co.,Ltd.; Shijiazhuang No.4 Pharmaceutical Co.,Ltd.; Pingguang Pharmaceutical Limited; Cardiatic Care
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Increasing prevalence of cardiovascular diseases, particularly angina pectoris, is driving the demand for Nicorandil Preparations and contributing to the growth forecast of the market.

Advancements in drug delivery technologies and the development of more effective formulations are further boosting the Nicorandil Preparations market size.

Restraints2 items

Stringent regulatory requirements and the need for extensive clinical trials are limiting the entry of new players into the Nicorandil Preparations market and affecting its growth.

Side effects associated with Nicorandil, such as headache and hypotension, are also acting as restraints to the market's expansion, impacting the overall growth forecast.

Opportunities2 items

Emerging economies with a large patient population and growing healthcare infrastructure present significant opportunities for the Nicorandil Preparations market to expand.

The increasing focus on personalized medicine and targeted therapies is expected to create new avenues for Nicorandil Preparations, contributing to the market's future growth.

Challenges2 items

Competition from alternative treatments and drugs, such as nitrates and beta-blockers, poses a significant challenge to the Nicorandil Preparations market size and its growth prospects.

Fluctuations in the global economy and pricing pressures can impact the profitability of Nicorandil Preparations manufacturers, affecting the market's overall growth forecast.

Market Segmentation

Loading chart…

Nicorandil Preparations Segmentation Breakdown7 items

Application

Hospital

Clinic

Other

Types

Tablet

Injection

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: high adoption rates, stringent policies, significant investments

Europe: increasing demographics, favorable policies, growing ecosystem maturity

Asia Pacific: increasing adoption, favorable policies, significant investments

Latin America: improving demographics, developing infrastructure, growing ecosystem maturity

Middle East & Africa: improving infrastructure, growing demographics, increasing adoption

Competitive Landscape

Actiza Pharmaceutical: regional expansion

Taj Pharmaceuticals: vertical integration

TSUBAME Pharma: premium pricing

Livealthbiopharma: OEM tie-ups

Torrent Pharmaceuticals Ltd: innovation pipeline

Chugai Pharmaceutical: local manufacturing

Key Nicorandil Preparations Companies19 items

Actiza Pharmaceutical

Taj Pharmaceuticals

TSUBAME Pharma

Livealthbiopharma

Torrent Pharmaceuticals Ltd

Chugai Pharmaceutical

Beijing Sihuan Kebao Pharmaceutical Co.,Ltd.

Tasly Pharmaceutical Group Co.,Ltd.

YANGTZE River Pharmaceutical Group

Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.

Chengdu Easton Biopharmaceuticals Co.,Ltd.

Henan Topfond Pharmaceutical Co.,Ltd.

Xi`an Han Feng Pharmaceutical Co.,Ltd.

Tonghua Renmin Pharmaceutical Co.,Ltd.

Liaoyuan City Baikang Pharmaceutical Co.,Ltd.

Shanxi Xinyu Pharmaceutical Co.,Ltd.

Shijiazhuang No.4 Pharmaceutical Co.,Ltd.

Pingguang Pharmaceutical Limited

Cardiatic Care

Market Ecosystem

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing Nicorandil Preparations

Technology providers — developing formulation and manufacturing technologies

Distributors / channel partners — delivering products to end users

Regulators/standards bodies — establishing and enforcing quality standards

Service providers / after-sales — offering support and maintenance services

End users / buyers — consuming Nicorandil Preparations for therapeutic purposes

Recent Industry Insights

Analyst Overview

Table of Contents